Teriflunomide and liver injury research information (PubMed) on: October 28, 2019, 04:12:17 pm #1 Teriflunomide has a "likelihood score" of D ("possible cause of clinically apparent liver injury but experience with its use is limited") in the Overview section about it in LiverTox: Clinical and Research Information on Drug-Induced Liver Injury issued by the National Institute of Diabetes and Digestive and Kidney Diseases, recently indexed in Pub Med. This section of the report was last updated in January 2017.. Teriflunomide Teriflunomide is an orally available immunomodulatory agent used to treat relapsing multiple sclerosis. Teriflunomide is associated with transient serum enzyme elevations during therapy and with ra... NCBI Bookshelf · ncbi.nlm.nih.gov Last Edit: October 29, 2019, 07:25:27 pm by agate Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
